Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.631
-0.009 (-1.37%)
Dec 24, 2024, 12:59 PM EST - Market closed
Channel Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 24, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | - | - | - | - |
| Enterprise Value | 5 | - | - | - | - |
| Debt / Equity Ratio | -1.60 | -0.20 | -0.15 | -0.30 | -0.07 |
| Quick Ratio | 0.35 | 0.01 | 0.01 | - | - |
| Current Ratio | 0.60 | 0.01 | 0.01 | - | 0.02 |
| Return on Assets (ROA) | -556.33% | -5663.30% | - | - | - |
| Buyback Yield / Dilution | -333.40% | -193.25% | - | - | - |
| Total Shareholder Return | -333.40% | -193.25% | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.